Carregant...
Eribulin and Confusion: A Previously Unknown Drug Side-Effect
Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman trea...
Guardat en:
| Publicat a: | Eur J Case Rep Intern Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SMC Media Srl
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7473676/ https://ncbi.nlm.nih.gov/pubmed/32908828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001708 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|